Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

24

Revenue 2017

Eylea

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Eylea was produced by Bayer.

Roche pharma sales strong for first half of 2015

Roche pharma sales strong for first half of 2015 13%, as competition from Regeneron/Bayer's Eylea (aflibercept) and off-label use of Avastin continues to erode sales.

NICE backs Bayer's Eylea in diabetic eye condition

NICE backs Bayer's Eylea in diabetic eye condition For DMO Eylea is given as a 2mg intravitreal injection every month for five months, followed by one injection every two months at a cost of £816 per dose. ... Details of the patient access scheme, which will see Bayer provide a simple discount to

NICE no for new eye disease drug

NICE no for new eye disease drug drugs on the market, including Novartis/Roche's Lucentis (ranibizumab) and Bayer/Regeneron's Eylea (aflibercept).

Roche, Novartis and Bayer gain NICE recommendations

Roche, Novartis and Bayer gain NICE recommendations Bayer has also been granted a recommendation for a new licence for its eye disease drug Eylea (aflibercept). ... In the draft final appraisal determination NICE recommends Eylea for the treatment of patients with diabetic macular oedema (DMO) - a

Eylea growth closes the gap with Lucentis

Eylea growth closes the gap with Lucentis Bayer/Regeneron’s drug eye disease drug set for blockbuster status.  . Bayer and Regeneron's eye disease therapy Eylea is on course to break into the blockbuster club this year, after ... Armed with new indications such as diabetic macular edema (DME),

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
90TEN

90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...